Brought to you by
ECR 2015 / C-1449
When, Why, and How of Thoracic Duct Embolization
This poster is published under an open license. Please read the disclaimer for further details.
Congress: ECR 2015
Poster No.: C-1449
Type: Educational Exhibit
Keywords: Trauma, Treatment effects, Sclerosis, Embolisation, MR, Lymphography, Fluoroscopy, Lymph nodes, Interventional vascular, Interventional non-vascular
Authors: J. F. B. Chick, N. Chauhan, A. Suzuki Han; Boston, MA/US
DOI:10.1594/ecr2015/C-1449

Background

The thoracic duct is the largest lymphatic conduit, draining upwards of seventy-five percent of lymphatic fluid, and extending from the cisterna chyli to the left jugulovenous angle. The lengthy course of the thoracic duct predisposes it to injury from a variety of iatrogenic causes including: thoracic, cardiac, and head and neck surgeries as well as spontaneous benign or malignant lymphatic obstructions. Disruption of the thoracic duct frequently results in chylothoraces that subsequently cause an immunocompromised state, result in nutritional depletion, and impair respiratory function, but disruption may also result in chylopericardium and persistent postoperative chylous wound drainage. Although conservative dietary treatments exist, the majority of thoracic duct injuries require thoracic duct embolization and ligation techniques. Such procedures have been found to be upwards of seventy-four percent successful with few complications.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more